≡

Polyclonal Antibody to Complement Component 9 (C9)

SPECIFITY

The antibody is a cavia polyclonal antibody raised against C9. It has been selected for its ability to recognize C9 in immunohistochemical staining and western blotting.

USAGE

Western blotting:0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Mainz Identifizierung neuer potentieller Biomarker für das Kolonkarzinom sowie dessen Vorstufen Info:Source
Scientific Reports Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice pubmed:27444648
FASEB Journal Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia Pubmed:29279353
Catalog No. Related products for research use of Oryctolagus cuniculus (Rabbit) Organism species Applications (RESEARCH USE ONLY!)
RPB823Rb01 Recombinant Complement Component 9 (C9) Positive Control; Immunogen; SDS-PAGE; WB.
PAB823Rb01 Polyclonal Antibody to Complement Component 9 (C9) WB; IHC; ICC; IP.
PAB823Rb51 Polyclonal Antibody to Complement Component 9 (C9) WB,IHC